Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on diet & genetics. Browse all Diet & Genetics education

Gut inflammation is not just about what you eat. The intestinal lining, the immune cells beneath it, and the trillions of microbes living in the gut all interact under instructions written partly in your DNA. Two people can eat the same meal and mount very different inflammatory responses, and a meaningful part of that difference is genetic.

This article explains how specific gene variants shape the way your gut senses microbes, maintains its barrier, and dials inflammation up or down — and what genetic insight can and cannot tell you about your own biology.

The short answer

Genetic factors influence gut inflammation by shaping three systems: how your immune cells recognize bacteria, how tightly your intestinal barrier holds together, and how quickly inflammation resolves once it starts. Variants in genes such as NOD2, IL23R, ATG16L1, TNF, and IL10 each nudge one of those systems.

No single variant decides whether you develop gut inflammation. These are contributing factors that interact with diet, stress, infections, medications, and the microbiome. Understanding your genetic tendencies gives you context, not a diagnosis.

How gut inflammation actually starts

The gut faces an unusual challenge: it must tolerate helpful bacteria and food proteins while attacking genuine threats. It does this through a single layer of epithelial cells sealed by tight junctions, a mucus barrier, and a dense population of immune cells in the lining underneath.

When the barrier weakens or the immune system overreacts to normal gut bacteria, inflammatory signaling ramps up. Chronic, low-grade inflammation of this kind is a shared feature across conditions from inflammatory bowel disease to some cases of irritable bowel syndrome, and genetics helps set each person's threshold.

Gene variants that shape gut inflammation risk

NOD2 encodes a sensor inside immune cells that detects a component of bacterial cell walls. Loss-of-function variants in NOD2 are among the most established genetic associations with Crohn's disease, because they blunt the early bacterial-sensing response and disrupt the balance between tolerance and attack.

IL23R codes for part of the receptor for interleukin-23, a cytokine that drives inflammatory immune cells. Certain IL23R variants are protective and dampen this pathway, while others tilt it toward more inflammation. ATG16L1 influences autophagy — the cell's recycling and bacterial-clearance machinery — and a common variant is linked to impaired handling of gut microbes.

TNF (tumor necrosis factor) is a master inflammatory signal; the rs1800629 promoter variant can influence how much TNF is produced. IL10 encodes an anti-inflammatory cytokine that helps switch inflammation off, and reduced IL10 signaling is associated with earlier and more severe intestinal inflammation.

What the research shows

Large genome-wide association studies have identified more than 200 genetic regions linked to inflammatory bowel disease, with NOD2, IL23R, and ATG16L1 among the strongest and most replicated signals. This is one of the best-mapped examples of how immune and barrier genes converge on a single tissue.

Crucially, most people who carry these variants never develop overt gut disease. The variants shift probability, and environmental factors — antibiotics, diet quality, smoking, and the composition of the microbiome — determine whether that shifted probability ever becomes visible.

What genetic insight can and cannot do

Genetic testing can describe tendencies in the pathways that govern gut inflammation. It cannot tell you that you have a disease, and it cannot replace the clinical workup — endoscopy, imaging, stool studies, and bloodwork — that a gastroenterologist uses to diagnose and manage conditions.

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants that sit within inflammatory and barrier-related biological pathways. It is a peptide-pathway genetic test, not a pharmacogenomic test, and its role is to give you pathway-level context about your biology — information you can bring to a qualified provider. PlexusDx tells you about your biology; it does not tell you what to put in your body.

What to do with the information

Pathway insight is most useful as a conversation starter. If you carry variants that lean toward stronger inflammatory signaling, that context can inform how proactively you and your provider monitor gut symptoms, evaluate diet, and address barrier-supporting habits such as sleep, fiber intake, and stress management.

Genetics is a guide, not a guarantee. The same variant can play out very differently depending on lifestyle and environment, which is exactly why the goal is informed decisions with a clinician — not self-treatment based on a genotype.

Frequently Asked Questions

Can a genetic test diagnose gut inflammation?

No. A genetic test describes tendencies in pathways such as immune signaling and barrier function, but it cannot diagnose inflammation or any digestive condition. Diagnosis requires clinical evaluation — endoscopy, imaging, stool testing, and bloodwork ordered and interpreted by a qualified healthcare provider.

Which genes are most linked to gut inflammation?

NOD2, IL23R, and ATG16L1 are among the most strongly replicated genes associated with inflammatory bowel conditions, alongside TNF and IL10, which regulate how strongly inflammation switches on and off. Each contributes to risk rather than determining it, and environment heavily shapes the outcome.

If I carry a risk variant, will I get an inflammatory bowel condition?

Not necessarily. Most people carrying these variants never develop overt disease. Variants shift probability, but diet, smoking, antibiotic exposure, infections, and the microbiome determine whether that shifted probability becomes clinically visible. Genetics is one contributing factor among many, not a verdict.

What can I do with genetic pathway insight?

Use it as context for a provider conversation. Knowing you lean toward stronger inflammatory signaling can inform how closely you monitor symptoms and which lifestyle levers — fiber, sleep, stress, and diet quality — you prioritize. It supports informed decisions, not self-diagnosis or self-treatment.

Curious how your own inflammatory and barrier pathways are wired? Explore the Precision Peptide Genetic Test to see how your DNA shapes these biological pathways — insight you can bring to a conversation with your healthcare provider.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Diet & Genetics education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.